Clinical Trial

Effect of Sarcopenia on Clinical Outcome of Total Knee Arthroplasty

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
As human life expectancy increases, the prevalence of degenerative osteoarthritis of the knee joints is steadily rising, leading to a significant surge in the frequency of total knee arthroplasty (TKA). However, research on sarcopenia in the population that comprises the primary recipients of these orthopedic joint surgeries has been notably lacking. Since the release of the 2019 Consensus update on sarcopenia by the Asian Walking Group for Sarcopenia (AWGS) in 2020, research on sarcopenia has gained momentum in various domains. Yet, as previously mentioned, the field of orthopedics still lags behind in investigating sarcopenia. Therefore, it is believed that establishing the relationship between sarcopenia and surgical outcomes in the elderly, who are the primary targets of orthopedic joint replacement surgery, could offer insights to further enhance the results of joint replacement surgeries.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06136039
Lead Sponsor Gangnam Severance Hospital
Conditions Knee Osteoarthritis
Enrollment 150 participants
Start Date 2022-06-03
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-19